• DESC will highlight its role in advancing Dubai’s cybersecurity ecosystem and strengthening Dubai’s digital infrastructure
• The Center will showcase strategic initiatives designed to empower the next generation of cybersecurity talent 
• H.E. Al Shaibani: “We are committed to strengthening the cybersecurity ecosystem and building strategic partnerships across the public and private sectors.”

Dubai, UAE, 3rd May 2025, ZEX PR WIRE, The Dubai Electronic Security Center (DESC) is set to participate as the official government cybersecurity partner for the eighth consecutive year in the 14th edition of the Gulf Information Security Expo and Conference (GISEC Global 2025), taking place from May 6-8 at the Dubai World Trade Centre. 

The Center’s participation in GISEC Global 2025, which gathers over 25,000 cybersecurity professionals representing more than 160 countries, aligns with its strategic objectives aimed at advancing the Dubai Cyber Security Strategy and reinforcing Dubai’s position as one of the world’s digitally safest cities. This participation reflects the Center’s commitment to safeguarding digital infrastructure, fostering innovation, enhancing cyber resilience, and promoting robust cooperation at both the local and international levels.

During the three-day event, DESC will spotlight a number of key initiatives, including the “Dubai Cyber Challenge”, an exclusive competitive simulation designed to enhance the cyber readiness of Dubai government entities, and the “School of Cyber Defense” CTF competition, which attracted registrations from over 300 university students, engaging them in technical challenges and hands-on training. These programs form a key part of DESC’s ongoing efforts to build a pipeline of skilled cybersecurity professionals equipped to navigate evolving digital threats.

H.E. Yousuf Hamad Al Shaibani, CEO of the Dubai Electronic Security Center, commented:
“DESC’s participation in GISEC Global 2025 reflects our steadfast commitment to securing Dubai’s digital future through proactive cybersecurity measures, innovation-driven initiatives, and an integrated ecosystem that fosters collaboration by building partnerships across public and private sectors. GISEC continues to serve as a dynamic platform where industry leaders, experts, and innovators come together to shape the future of cybersecurity.”

“GISEC 2025 provides a critical platform for strategic engagement with global cybersecurity innovators, allowing us to gain insights into emerging technologies and anticipate future threats. These interactions directly support our efforts to create forward-looking policies, develop advanced cyber solutions, and empower national talent to lead in this field. Through such initiatives, we continue to strengthen Dubai’s position as a global hub for cybersecurity excellence and digital innovation,” Al Shaibani added. 

DESC experts will also take part in high-level panel discussions addressing key challenges and emerging trends in the cybersecurity landscape. The Center will also formalize strategic partnerships and Memorandums of Understanding (MoUs), aimed at enhancing cross-sector collaboration and strengthening national efforts to secure the cyber space.

Visitors to GISEC Global 2025 are invited to explore DESC’s initiatives at Stand A80 in Hall 7, where DESC will showcase its latest projects, including future-ready cybersecurity guidelines and certification programs designed to keep pace with the evolving digital landscape and strengthen national capabilities. The stand will also serve as a unique opportunity for attendees to engage with DESC’s experts and explore opportunities for joint collaboration.

Secure your pass and learn more: GISEC GLOBAL | The World’s Leading Cyber Security Exhibition | 6 – 8 May 2025

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

• Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
• Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
• Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
• Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
• Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

NSW, Australia, 3rd May 2025 – Dr. Katie Zippel, a respected general practitioner and DPhil candidate at Oxford University, has introduced pioneering research that sheds light on the role of social prescribing in cancer care. Her latest study, soon to be published in a leading peer-reviewed journal, highlights how non-medical interventions can significantly enhance the well-being and long-term health outcomes of individuals living with cancer.

With both professional expertise and personal experience as a breast cancer survivor, Dr. Zippel brings a unique perspective to this research. Her study explores how integrating social support systems, lifestyle medicine, and community-driven initiatives into primary healthcare can improve the overall survivorship experience for cancer patients.

Social prescribing is a revolutionary healthcare approach that enables medical professionals to refer patients to non-medical services that support mental, emotional, and physical well-being. These services include arts-based therapies, exercise programmes, gardening projects, and community-based support groups.

Dr. Zippel’s research emphasizes that cancer treatment should go beyond conventional medicine and include holistic interventions that help patients cope with the psychological and social challenges that come with a cancer diagnosis. Her study presents strong evidence that structured social prescribing programmes significantly reduce stress, enhance emotional resilience, and improve overall quality of life.

Key Findings from the Research

Dr. Zippel’s study explores the tangible benefits of social prescribing by analysing patient experiences across various healthcare settings, including hospitals and community clinics. The research identifies several key findings that underscore the impact of these programmes:

• Improved Mental Health: Patients engaged in social prescribing activities reported a 40% decrease in anxiety and depression symptoms compared to those receiving conventional treatment alone.
• Stronger Social Connections: Over 70% of participants noted significant improvements in social engagement, reducing their sense of isolation.
• Enhanced Physical Well-being: Patients who participated in prescribed exercise programmes experienced increased mobility, better energy levels, and overall improved health.
• Better Treatment Adherence: Patients involved in non-medical support activities demonstrated greater commitment to their medical treatments and healthier lifestyle choices.
• Long-Term Health Benefits: Individuals participating in social prescribing programmes were more likely to maintain a healthier lifestyle post-treatment, reducing the risk of cancer recurrence.

Bridging the Gap Between Medicine and Community Support

One of the core messages of Dr. Zippel’s research is the importance of bridging clinical medicine with community-based support systems. While medical treatments such as chemotherapy and radiation are essential in combating cancer, addressing the social determinants of health—such as loneliness, mental well-being, and financial stress—can play an equally crucial role in recovery.

A key innovation within Dr. Zippel’s work is her focus on narrative medicine, an approach that utilises storytelling to foster understanding, connection, and empowerment among cancer patients. By encouraging patients to share their experiences, she is helping create a more compassionate and patient-centred healthcare model.

A Global Call for Change in Cancer Survivorship Care

The findings from Dr. Zippel’s research have far-reaching implications for healthcare policies worldwide. As medical systems search for sustainable ways to improve cancer survivorship care, her work provides strong evidence supporting the expansion of social prescribing initiatives.

Going forward, Dr. Zippel aims to collaborate with global healthcare providers and policymakers to integrate social prescribing into mainstream medical practices, ensuring more patients have access to holistic, community-driven care.

A Personal Mission for Healthcare Innovation

For Dr. Zippel, this research is more than an academic pursuit—it is a deeply personal mission. As a breast cancer survivor, she understands firsthand the challenges of navigating treatment and recovery. Her lived experience has inspired her dedication to advancing equitable healthcare solutions, particularly for underserved and rural communities.

Beyond research, Dr. Zippel is actively engaged in primary healthcare delivery as part of a multidisciplinary team. Her work spans rural general practice, mental health support, and public health research, all aimed at bridging clinical medicine with social support systems to improve patient outcomes.

A Vision for Holistic Wellness

Through her online platform and research initiatives, Dr. Zippel explores the connection between daily habits, community engagement, and overall health. She shares insights on lifestyle medicine, disease prevention, and the power of human connection in healthcare. Her blog serves as an educational hub, featuring personal narratives, health education posts, and evidence-based research from leading medical journals.

To further her mission, Dr. Zippel plans to introduce video content and interactive discussions, allowing patients and healthcare professionals to engage with her research more directly. By blending storytelling with science, she hopes to make medical knowledge more accessible and relatable.

Join the Movement: Advocating for Social Prescribing

Dr. Katie Zippel’s groundbreaking research is leading a global shift in how cancer care is approached. She urges healthcare professionals, policymakers, and researchers to recognise the transformative impact of social prescribing in improving cancer survivorship.

By advocating for these innovative, community-centred healthcare solutions, Dr. Zippel is setting the stage for a future where cancer care is not only about medical treatment but also about fostering holistic healing and support networks that prioritise the well-being of every patient.

About Dr. Katie Zippel

Dr. Katie Zippel is a highly regarded general practitioner and a DPhil candidate at Oxford University, specialising in social prescribing for cancer care. Her work is rooted in evidence-based healthcare, lifestyle medicine, and patient-centred approaches, particularly in rural and remote areas. Through her research and advocacy, she continues to drive a global movement towards more compassionate and inclusive healthcare practices.

Media Contact

Organization: Dr. Katherine Zippel PTY LTD

Contact Person: Suzie Green

Website: https://katiezippel.com

Email: Send Email

Contact Number: +61474932326

Address:81-83 Campbell Street, Surry Hills, NSW, 2010

City: NSW

Country:Australia

Release id:27268

The post Dr. Katie Zippel Unveils Pioneering Research on Social Prescribing for Cancer Care appeared first on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section